Secondary breast cancer treatment in Germany includes TACE treatment , TACP, and dendritic cell therapy in Germany, with full support for international patients and treatment guided by experienced German specialists.

Treatment Options for Secondary Breast Cancer in Germany

Treatment options for secondary breast cancer in Germany are tailored to offer both local and systemic control of the disease while enhancing quality of life. Secondary breast cancer, also known as metastatic breast cancer, occurs when cancer cells spread from the breast to other parts of the body such as the liver, lungs, bones, or brain. While not considered curable, this form of cancer is manageable with a combination of therapies aimed at slowing progression, controlling symptoms, and improving long-term stability.

Germany is recognized for its personalized oncology programs that integrate advanced imaging, immune profiling, and targeted interventions. Leading German cancer centers offer modern non-surgical therapies such as dendritic cell therapy in Germany, TACE therapy, and TACP treatment, all supported by experienced specialists and comprehensive support services through TIG (Treatment in Germany).

Understanding Secondary Breast Cancer

Secondary breast cancer refers to the spread of primary breast cancer to distant organs. It may recur months or years after the initial diagnosis, even after surgery, chemotherapy, or radiation. Common areas of metastasis include:

• Bone metastases causing pain or fractures
• Liver metastases affecting liver function
• Lung metastases leading to breathing issues
• Brain metastases resulting in neurological symptoms

Regular follow-up, blood work, and imaging are essential for early detection and ongoing treatment planning in Germany.

Dendritic Cell Therapy for Secondary Breast Cancer in Germany

Dendritic cell therapy for secondary breast cancer in Germany, is one of the most innovative immunotherapy treatments in Germany. This personalized therapy strengthens the immune system to detect and destroy cancer cells. It is particularly effective in patients with metastatic disease who no longer respond to standard therapies.

The therapy involves isolating monocytes from the patient’s blood and converting them into dendritic cells in an EU-GMP-certified laboratory. These dendritic cells are then exposed to tumor-specific antigens and reintroduced into the patient as a dendritic cell vaccine, activating immune cells to attack cancer throughout the body.

Steps of Dendritic Cell Therapy in Germany:

• Blood collection (around 250–300 ml)
• Extraction and cultivation of dendritic cells
• Exposure to cancer-specific antigens
• Vaccine maturation and reinfusion

This therapy is performed by Prof. Gansauge in Berg, a leading authority in personalized immunotherapy.

Cost of Dendritic Cell Therapy in Germany

The cost of dendritic cell therapy in Germany is €24,000, which includes cell processing, vaccine creation, and administration across multiple sessions.

Benefits of Dendritic Cell Therapy:

• Personalized immune activation
• Low toxicity and mild side effects
• Suitable for long-term immune surveillance
• Can be used alongside other non-surgical therapies

Patients with secondary breast cancer in Germany often report improved energy, symptom control, and stability after undergoing dendritic cell therapy.

TACE Therapy for Secondary Breast Cancer with Liver Metastasis in Germany

TACE therapy (Transarterial Chemoembolization) in Germany, is a minimally invasive treatment used when secondary breast cancer has spread to the liver. It delivers chemotherapy drugs directly into the arteries supplying the liver tumors while simultaneously blocking those blood vessels to cut off the tumor’s nutrients.

TACE treatment in Germany is performed under imaging guidance using a catheter inserted through a small incision. It targets liver metastases while minimizing systemic side effects, making it suitable for patients with limited treatment options.

Key Advantages of TACE Therapy:

• Localized drug delivery
• Short hospital stay and faster recovery
• Reduced toxicity compared to traditional chemotherapy
• Can be repeated based on patient response

TACE therapy is led by Prof. Vogl Frankfurt Germany, a global leader in interventional oncology and TACE therapy in Germany. He also oversees TACP therapy for secondary breast cancer cases involving liver or pelvic metastases.

Cost of TACE Therapy in Germany

The cost of TACE therapy in Germany typically ranges between €8,000 and €9,000 per session, depending on tumor size and session frequency.

TACP (Transarterial Chemo Perfusion) Therapy for Secondary Breast Cancer in Germany

TACP (Transarterial Chemo Perfusion) is a specialized technique used in Germany to treat metastatic breast cancer that has spread to the liver or pelvis. Unlike systemic chemotherapy, TACP therapy for secondary breast cancer delivers chemotherapy through arterial perfusion, allowing higher local drug concentration with fewer side effects.

This method is often used in patients with large or difficult-to-reach tumors and is guided by real-time imaging to ensure precision.

Benefits of TACP Therapy:

• High-dose chemotherapy directly to the tumor
• Reduced systemic exposure
• Effective in resistant or advanced metastatic breast cancer
• Often combined with immunotherapy for enhanced results

TACP is administered at leading German oncology clinics and may be integrated into broader multimodal treatment strategies.

Cost of TACP Therapy in Germany

The cost of TACP therapy in Germany is generally comparable to TACE therapy, ranging from €8,000 to €9,000 per session, depending on tumor location, size, and the number of sessions required.

Combining Dendritic Cell Therapy with TACE and TACP for Secondary Breast Cancer in Germany

A combined approach using dendritic cell therapy, TACE, and TACP therapy in Germany allows for a comprehensive, multi-layered strategy to treat secondary breast cancer. While dendritic cell vaccines stimulate the body’s immune system to target cancer systemically, TACE and TACP therapies work locally to cut off blood supply and deliver chemotherapy directly to metastatic tumors, especially in the liver or pelvis.

This combination offers the benefit of both systemic immune engagement and localized tumor control, often improving patient response and long-term outcomes. Treatment plans are personalized by German specialists to match tumor biology, metastatic spread, and overall health.

Monitoring and Imaging in German Breast Cancer Treatment

Advanced diagnostic imaging plays a central role in managing secondary breast cancer in Germany. Tools such as:

• PET-CT and MRI to locate metastases
• Immune profiling to guide dendritic cell therapy
• Tumor markers to track response
• Liver function tests for TACE or TACP evaluation

These assessments ensure treatments remain personalized and adaptive throughout the treatment process. According to the Australian Cancer Society, integrating immunotherapy with targeted loco regional techniques improves disease control and patient comfort in metastatic breast cancer.

Why International Patients Choose Germany for Metastatic Breast Cancer Care

Germany’s comprehensive approach to secondary breast cancer treatment involves precision medicine, integrated diagnostics, and access to the best oncologist in Germany, experienced radiologists, and immunotherapy experts in Germany. Through TIG (Treatment in Germany), international patients receive full logistical and medical support.

TIG helps with:

• Appointment booking with oncology experts
• Interpretation and translation
• Travel and visa coordination
• post-treatment monitoring

Patients from abroad benefit from access to emerging therapies like dendritic cell therapy, TACE, and TACP therapy in Germany, which may not be widely available in other countries.

🌍Why Patients Worldwide Prefer Our Medical Services in Germany – Key Benefits Explained:

Frequently Asked Questions (FAQs)

What is secondary breast cancer?
It is cancer that has spread from the breast to other organs, also called metastatic breast cancer.

Is dendritic cell therapy used for metastatic breast cancer in Germany?
Yes, it is offered as a non-toxic, personalized treatment to boost immune response.

How much does dendritic cell therapy cost in Germany?
The cost of dendritic cell therapy in Germany €24,000, covering all stages of vaccine preparation and administration.

What is TACE therapy and who can benefit from it?
TACE is a localized treatment for liver metastases in breast cancer patients, offering tumor control with fewer side effects.

Can these treatments be combined?
Yes, dendritic cell therapy, TACE, and TACP are often combined for optimal results.

What is the success rate of dendritic cell therapy in breast cancer?
Many patients experience improved stability and symptom control with dendritic cell therapy in Germany.

How is liver metastasis from breast cancer treated in Germany?
Germany uses TACE therapy and TACP therapy to treat liver metastases by delivering targeted chemotherapy directly to tumors.

Is dendritic cell therapy FDA-approved for secondary breast cancer?
Dendritic cell therapy is not FDA-approved for secondary breast cancerin the USA but is performed in Germany under EU-GMP standards for safety.

Is Germany a good option for international breast cancer patients?
Yes, many choose Germany for its personalized therapies and complete logistical support via TIG (Treatment in Germany) at www.treatmentingermany.de. 

Who is the best cancer specialist for secondary Breast cancer in Germany?
Germany has many highly experienced oncologists and specialized cancer centers known for advanced diagnostics and personalized treatment approaches. The “best” cancer specialist depends on the specific cancer type and treatment needs. Some of the most recognized cancer experts include professors working at leading hospitals such as Charité University Hospital (Berlin), University Hospital Heidelberg, University Hospital Munich (LMU), and Frankfurt University Hospital.